StockData
PALXOTCSemiconductors & Related DevicesFiscal year ends December 31

Palomino Laboratories Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$14.00−0.32 (-2.23%)

Close on Oct 15, 2026

Market cap
$305.46M
P/E (TTM)
–
Dividend yield
–

About Palomino Laboratories

Semiconductors & Related Devices, SIC 3674

Palomino Laboratories Inc. is a pre-revenue technology company developing optical interconnect solutions to transmit data using light instead of conventional copper wiring. The company designs optical transceivers incorporating gallium nitride microLEDs, which can integrate directly onto computer chips or connectors. Its product development focuses on high-speed, low-power optical links for PCIe Gen 6+ and Ethernet backplanes. Palomino targets organizations operating data-intensive environments, including hyperscale data center operators, artificial intelligence and machine learning infrastructure providers, high-performance computing clusters, networking equipment manufacturers, and semiconductor firms implementing chiplet architectures.

Palomino operates under a fabless business model, focusing on device design, packaging, and commercialization rather than internal fabrication. The company conducts research and development activities in collaboration with the University of California, Santa Barbara, utilizing licensed microLED technology. Its principal executive offices are located in Goleta, California.

Summary of the business section of Palomino Laboratories's latest annual report, written by StockData.

Company profile

Company

Legal name
Palomino Laboratories Inc.
Founded
2022
Headquarters
Goleta, CA
Address
130 Castilian Drive, Suite 102 93117
Phone
(917) 200-3734
Employees
5, Dec 31, 2025
Industry
Semiconductors & Related Devices
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
KNAV CPA LLP, Atlanta, Georgia

Stock & identifiers

Ticker
PALX
Exchange
OTC
IPO date
Apr 14, 2026
Shares outstanding
28M, Aug 4, 2026
Filer category
<br>Emerging growth company
Stock splits
1-for-3.25 reverse, Nov 14, 2025
SEC CIK
1938569
CUSIP
909233108
ISIN
US9092331084
EIN
88-1619619

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Richard OgawaSecretary, Director1,882,500
Jeffrey B. ShealyPresident and CEO, Director4,666,666
Jason TuChief Accounting Officer125,001
Steven DenbaarsDirector1,762,500

Employees

Headcount reported in annual reports

“of December 31, 2025, we had 5 full time employees, no part-time employees, and 13 consultants.”

Corporate history

Events identified from SEC filings

DateEventDetails
Aug 5, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 6, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 29, 2025Name changeName changed from Unite Acquisition 3 Corp. to Palomino Laboratories Inc.